Tixylix 120ml is primarily indicated in conditions like Acceleration of myeloid recovery following bone marrow transplantation, Adjunct in ganciclovir treatment, Advanced ovarian cancer, All forms of epilepsy, Allergy, Anaphylactic reactions, Dermatologicals, Haemolytic disease of newborn, Insect bites, Insomnia, Metastatic germ cell cancers (seminoma and teratoma), Motion sickness, Myoclonus, Nausea, vertigo, labyrinthine disorders, NSAID associated ulceration, Parkinsonism, Prevention of hypokalaemia, Severe vomiting in pregnancy, Transcervical operative procedures in first trimester, Urticaria, and can also be given in adjunctive therapy as an alternative drug of choice in Epilepsy, Night sedation and insomnia, Pain, Severe nausea, vomiting (acute attacks).
Tixylix 120ml(HCI) is contraindicated in conditions like Epilepsy, Glucoma,Prostatic hypertrophy.
The severe or irreversible adverse effects of Tixylix 120ml(HCI), which give rise to further complications include Pheochromocytoma. The signs and symptoms that are produced after the acute overdosage of Tixylix 120ml(HCI) include Seizures, Blurred vision, Respiratory depression, Hallucinations, Delirium, Ataxia, CNS stimulation, Anxiety, Deep sleep, Akathisia, Hyperexcitability. The symptomatic adverse reactions produced by Tixylix 120ml(HCI) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Anxiety, Insomnia, Nervousness, Dry mouth, Blurred vision, Confusion, Sedation, CNS depression, Incoordination, CNS excitation
Tixylix 120mlshould be used with caution in bone marrow depression. Patients should observe caution while driving or performing other task requiring alertness because it may cause drowsiness. It should be used with caution in patients with urinary retention, history of bronchial asthma, hyperthyroidism, cardiovascular or liver disease. It should be used with caution in person with acute or chronic respiratory impairment, especially in children. Do not give S/C because irritation or lesion may occur.